Literature DB >> 22407614

Serotonin and blood pressure regulation.

Stephanie W Watts1, Shaun F Morrison, Robert Patrick Davis, Susan M Barman.   

Abstract

5-Hydroxytryptamine (5-HT; serotonin) was discovered more than 60 years ago as a substance isolated from blood. The neural effects of 5-HT have been well investigated and understood, thanks in part to the pharmacological tools available to dissect the serotonergic system and the development of the frequently prescribed selective serotonin-reuptake inhibitors. By contrast, our understanding of the role of 5-HT in the control and modification of blood pressure pales in comparison. Here we focus on the role of 5-HT in systemic blood pressure control. This review provides an in-depth study of the function and pharmacology of 5-HT in those tissues that can modify blood pressure (blood, vasculature, heart, adrenal gland, kidney, brain), with a focus on the autonomic nervous system that includes mechanisms of action and pharmacology of 5-HT within each system. We compare the change in blood pressure produced in different species by short- and long-term administration of 5-HT or selective serotonin receptor agonists. To further our understanding of the mechanisms through which 5-HT modifies blood pressure, we also describe the blood pressure effects of commonly used drugs that modify the actions of 5-HT. The pharmacology and physiological actions of 5-HT in modifying blood pressure are important, given its involvement in circulatory shock, orthostatic hypotension, serotonin syndrome and hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407614      PMCID: PMC3310484          DOI: 10.1124/pr.111.004697

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  429 in total

1.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

2.  Cardiovascular effects of microinjection of low doses of serotonin into the NTS of unanesthetized rats.

Authors:  J C Callera; L G Bonagamba; C Sévoz; R Laguzzi; B H Machado
Journal:  Am J Physiol       Date:  1997-04

3.  5-HT2B receptor mRNA in guinea pig superior cervical ganglion.

Authors:  N R Newberry; C J Watkins; A Volenec; T P Flanigan
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

4.  Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.

Authors:  S Jähnichen; E Glusa; H H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-12-04       Impact factor: 3.000

5.  On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.

Authors:  B Saletu; J Grünberger; L Linzmayer
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 6.  Local modulation of adrenergic neurotransmission in blood vessels.

Authors:  J T Shepherd; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  Role of 5-HT on increased permeability of blood-brain barrier under heat stress.

Authors:  H S Sharma; P K Dey
Journal:  Indian J Physiol Pharmacol       Date:  1984 Oct-Dec

8.  Changes in systemic and regional haemodynamics during 5-HT7 receptor-mediated depressor responses in rats.

Authors:  P De Vries; P A De Visser; J P Heiligers; C M Villalón; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-04       Impact factor: 3.000

9.  Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.

Authors:  R W M van den Broek; P Bhalla; A Massen VanDenBrink; R de Vries; H S Sharma; P R Saxena
Journal:  Cephalalgia       Date:  2002-03       Impact factor: 6.292

10.  A serotonergic system in veins: serotonin transporter-independent uptake.

Authors:  A Elizabeth Linder; Wei Ni; Theodora Szasz; Robert Burnett; Jessica Diaz; Timothy J Geddes; Donald M Kuhn; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2008-03-05       Impact factor: 4.030

View more
  98 in total

1.  Environment Influencing Serotonin Syndrome Induced by Ecstasy Abuse.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan
Journal:  Ann Forensic Res Anal       Date:  2017-03-07

Review 2.  Serotonin and Serotonin Transporters in the Adrenal Medulla: A Potential Hub for Modulation of the Sympathetic Stress Response.

Authors:  Rebecca L Brindley; Mary Beth Bauer; Randy D Blakely; Kevin P M Currie
Journal:  ACS Chem Neurosci       Date:  2017-04-13       Impact factor: 4.418

Review 3.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

4.  Fluoxetine and Raynaud's phenomenon: friend or foe?

Authors:  Charles Khouri; Thomas Gailland; Marion Lepelley; Matthieu Roustit; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2017-06-04       Impact factor: 4.335

5.  Effects of tryptophan, serotonin, and kynurenine on ischemic heart diseases and its risk factors: a Mendelian Randomization study.

Authors:  Mengyu Li; Man Ki Kwok; Shirley Siu Ming Fong; Catherine Mary Schooling
Journal:  Eur J Clin Nutr       Date:  2020-03-04       Impact factor: 4.016

6.  Serotonin and dopamine in essential hypertension.

Authors:  Charles T Stier
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

Review 7.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

8.  Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.

Authors:  Justin D Crane; Rengasamy Palanivel; Emilio P Mottillo; Adam L Bujak; Huaqing Wang; Rebecca J Ford; Andrew Collins; Regje M Blümer; Morgan D Fullerton; Julian M Yabut; Janice J Kim; Jean-Eric Ghia; Shereen M Hamza; Katherine M Morrison; Jonathan D Schertzer; Jason R B Dyck; Waliul I Khan; Gregory R Steinberg
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

Review 9.  Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.

Authors:  Andrea Rague; Kevin Tidgewell
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

10.  Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK1 pathway in the rat carotid artery.

Authors:  Shun Watanabe; Takayuki Matsumoto; Mirai Oda; Kosuke Yamada; Junya Takagi; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2015-11-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.